Collaborative Stage Data Set - Revised 06/12/2013 FINAL
CS Site-Specific Factor 22
Multigene Signature Method
- Note 1: Multigene signatures or classifiers are assays of a panel of genes from a tumor specimen, intended to provide a quantitative assessment of the likelihood of response to chemotherapy and to evaluate prognosis or distant recurrence. Oncotype DX and MammaPrint (also called MammoPrint) are two commercially available genomic tests.
- Note 2: Code the type of test performed. The same test should be used to record information in CS Site-Specific Factors 22 and 23.
- Note 3: This information may not be available at diagnosis and may require follow-up with the physician.
|040||Test performed, type of test unknown|
|988||Not applicable: Information not collected for this case|
(If this information is required by your standard setter, use of code 988 may result in an edit error.)
|997||OBSOLETE DATA CONVERTED V0203|
See code 040
Test ordered, results not in chart
|998||Test not done (test not ordered and not performed)|
|999||Unknown or no information|
Not documented in patient record